ONEOK Inc
OKE
88.05
-1.18
-1.32%
ONEOK Inc
US · OKE
#378 by market cap
Listed 1970
88.05
-1.18
-1.32%
Live - 5344 symbols - heartbeat 76s ago
· 2026-10-08 07:00
Pre-market
88.61
+0.64%
After-hours
88.05
0.00%
Overnight
88.12
+0.08%
- Market cap
- 55.51B
- P/E (TTM)i
- 15.21
- P/Bi
- 2.42
- EPSi
- 5.42
- Div yieldi
- 4.77%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on OKE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.56, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +54.99% YoY
Margins
- Gross margin
- 26.00%
- Operating margin
- 17.31%
- Net margin
- 10.09%
Key ratios & quality
- Enterprise valuei
- 88.25B
- PEG ratioi
- 0.60
- Altman Z-Scorei
- 1.56
PEG uses trailing P/E against the 3-year net income growth rate (25.37%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.59B | 10.16B | 8.54B | 16.54B | 22.39B | 17.68B | 21.70B | 33.63B |
| Gross profit | 2.74B | 2.90B | 2.85B | 3.66B | 3.85B | 4.98B | 7.25B | 8.74B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.83B | 1.92B | 1.97B | 2.60B | 2.81B | 4.23B | 5.06B | 5.82B |
| Pretax profit | 1.52B | 1.65B | 802.32M | 1.98B | 2.25B | 3.50B | 4.11B | 4.49B |
| Tax | 362.90M | 372.41M | 189.51M | 484.00M | 528.00M | 838.00M | 998.00M | 1.03B |
| Net profit | 1.16B | 1.28B | 612.81M | 1.50B | 1.72B | 2.66B | 3.11B | 3.46B |
| Basic EPS | 3 | 3 | 1 | 3 | 4 | 5 | 5 | 5 |
| Diluted EPS | 2.78 | 3.07 | 1.42 | 3.35 | 3.84 | 5.48 | 5.17 | 5.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 8.04B | 7.89B | 8.63B | 9.07B | 9.62B | 12.05B |
| Gross profit | 2.01B | 2.16B | 2.29B | 2.28B | 2.19B | 2.42B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.26B | 1.45B | 1.57B | 1.54B | 1.44B | 1.60B |
| Pretax profit | 888.00M | 1.11B | 1.24B | 1.25B | 1.02B | 1.27B |
| Tax | 197.00M | 260.00M | 297.00M | 274.00M | 245.00M | 299.00M |
| Net profit | 691.00M | 853.00M | 940.00M | 978.00M | 776.00M | 967.00M |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 2 |
| Diluted EPS | 1.04 | 1.34 | 1.49 | 1.55 | 1.23 | 1.53 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.40B | 1.47B | 1.87B | 2.37B | 2.55B | 3.11B | 4.24B | 4.49B |
| Cash & ST investments | 11.98M | 20.96M | 524.50M | 146.39M | 220.00M | 338.00M | 733.00M | 78.00M |
| Inventory | 437.84M | 506.68M | 370.99M | 580.90M | 581.00M | 639.00M | 748.00M | 948.00M |
| Total assets | 18.23B | 21.81B | 23.08B | 23.62B | 24.38B | 44.27B | 64.07B | 66.64B |
| Total current liabilities | 2.11B | 2.02B | 1.34B | 3.18B | 3.05B | 3.45B | 4.72B | 6.37B |
| Short-term debt | 509.42M | 229.53M | 21.26M | 909.60M | 937.00M | 484.00M | 1.06B | 2.06B |
| Long-term debt | 8.87B | 12.48B | 14.23B | 12.75B | 12.70B | 21.18B | 31.02B | 30.76B |
| Total liabilities | 11,652,128,000.00 | 15,586,170,000.00 | 17,036,356,000.00 | 17,606,450,000.00 | 17,885,000,000.00 | 27,782,000,000.00 | 41,936,000,000.00 | 44,072,000,000.00 |
| Total equity | 6.58B | 6.23B | 6.04B | 6.02B | 6.49B | 16.48B | 22.13B | 22.57B |
| Retained earnings | 0 | 0 | 0 | 0 | 50.00M | 868.00M | 1.58B | 2.37B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.12B | 3.90B | 5.19B | 4.49B | 5.54B | 5.31B |
| Cash & ST investments | 141.00M | 97.00M | 1.20B | 78.00M | 172.00M | 161.00M |
| Inventory | 905.00M | 858.00M | 871.00M | 948.00M | 1.14B | 1.06B |
| Total assets | 64.26B | 64.52B | 66.62B | 66.64B | 68.20B | 68.55B |
| Total current liabilities | 6.18B | 6.65B | 5.74B | 6.37B | 7.81B | 7.20B |
| Short-term debt | 2.26B | 2.84B | 1.74B | 2.06B | 2.89B | 2.25B |
| Long-term debt | 29.78B | 29.63B | 31.99B | 30.76B | 30.76B | 30.77B |
| Total liabilities | 42,143,000,000.00 | 42,620,000,000.00 | 44,459,000,000.00 | 44,072,000,000.00 | 45,715,000,000.00 | 45,468,000,000.00 |
| Total equity | 22.12B | 21.90B | 22.16B | 22.57B | 22.49B | 23.08B |
| Retained earnings | 1.57B | 1.77B | 2.05B | 2.37B | 2.47B | 2.76B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.19B | 1.95B | 1.90B | 2.55B | 2.91B | 4.42B | 4.89B | 5.60B |
| Depreciation & amortization | 428.56M | 476.54M | 578.66M | 622.00M | 626.00M | 769.00M | 1.13B | 1.51B |
| Free cash flow | 45.24M | -1.90B | -296.31M | 1.85B | 1.70B | 2.83B | 2.87B | 2.45B |
| Dividends paid | -1.34B | -1.46B | -1.61B | -1.67B | -1.67B | -1.84B | -2.31B | -2.58B |
| Stock buybacks / issuance | 1.20B | 29.04M | 969.76M | -- | 0 | 0 | -159.00M | -75.00M |
| Ending cash balance | 11.98M | 20.96M | 524.50M | 146.00M | 220.00M | 338.00M | 733.00M | 78.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 904.00M | 1.53B | 1.62B | 1.55B | 934.00M | 2.05B |
| Depreciation & amortization | 380.00M | 368.00M | 378.00M | 388.00M | 378.00M | 387.00M |
| Free cash flow | 275.00M | 776.00M | 820.00M | 576.00M | 70.00M | 1.44B |
| Dividends paid | -643.00M | -644.00M | -648.00M | -648.00M | -674.00M | -674.00M |
| Stock buybacks / issuance | -30.00M | 0 | 0 | -45.00M | -- | -- |
| Ending cash balance | 141.00M | 97.00M | 1.20B | 78.00M | 172.00M | 161.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.01 | 19.95 | 9.97 | 24.86 | 27.52 | 23.14 | 18.10 | 17.17 |
| ROA %i | 6.56 | 6.38 | 2.73 | 6.42 | 7.17 | 7.74 | 5.60 | 5.19 |
| ROIC %i | 9.85 | 9.50 | 5.88 | 10.23 | 11.21 | 11.35 | 9.32 | 9.13 |
| 5-year avg ROE %i | 48.20 | 47.91 | 39.34 | 17.47 | 20.26 | 21.09 | 20.72 | 22.16 |
| EBIT margin %i | 15.78 | 21.08 | 17.74 | 16.43 | 13.07 | 24.68 | 25.26 | 18.65 |
| FCF / sales %i | 0.36 | -- | -- | 11.18 | 7.61 | 15.99 | 13.21 | 7.28 |
| Current ratioi | 0.66 | 0.73 | 1.39 | 0.75 | 0.84 | 0.90 | 0.90 | 0.71 |
| Quick ratioi | 0.39 | 0.42 | 1.01 | 0.50 | 0.57 | 0.59 | 0.65 | 0.49 |
| Debt / assetsi | 51.61 | 58.33 | 62.12 | 58.14 | 56.20 | 48.95 | 50.07 | 49.24 |
| LT debt / equityi | 135.26 | 200.66 | 236.93 | 213.18 | 196.55 | 128.51 | 182.07 | 136.78 |
| Interest coveragei | 4.23 | 4.36 | 2.13 | 3.71 | 4.33 | 5.04 | 4.00 | 3.52 |
| Revenue CAGR (3Y) %i | 17.50 | 4.45 | -11.14 | 9.51 | 30.11 | 27.43 | 9.47 | 14.53 |
| Net income CAGR (3Y) %i | 67.52 | 53.71 | 16.47 | 9.21 | 10.43 | 63.10 | 26.48 | 25.37 |
| FCF CAGR (3Y) %i | -- | -- | -- | 244.45 | -- | -- | 15.74 | 12.82 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.03 | 16.05 | 17.14 | 17.17 | 16.15 | 16.33 |
| ROA %i | 5.58 | 5.67 | 5.68 | 5.19 | 5.33 | 5.49 |
| ROIC %i | 9.11 | 9.37 | 9.31 | 9.13 | 8.95 | 9.10 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.69 | 21.09 | 20.10 | 18.65 | 18.19 | 16.64 |
| FCF / sales %i | 12.25 | 10.31 | 9.25 | 7.28 | 6.37 | 7.38 |
| Current ratioi | 0.67 | 0.59 | 0.90 | 0.71 | 0.71 | 0.74 |
| Quick ratioi | 0.45 | 0.39 | 0.66 | 0.49 | 0.49 | 0.52 |
| Debt / assetsi | 49.86 | 50.32 | 50.63 | 49.24 | 49.34 | 48.17 |
| LT debt / equityi | 139.40 | 135.71 | 144.86 | 136.78 | 137.60 | 134.16 |
| Interest coveragei | 3.74 | 3.57 | 3.57 | 3.52 | 3.60 | 3.69 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Refined Products and Crude is the largest reported line at 59.21% of revenue, across 5 reported segments.
- Natural Gas Liquids follows at 38.12%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Refined Products and Crude59.21%
Natural Gas Liquids38.12%
Natural Gas Gathering and Processing15.59%
Natural Gas Pipelines3.73%
Quote time 2026-10-08 07:00:05 · For reference only, not investment advice and not tailored to your situation.